119 related articles for article (PubMed ID: 3735805)
21. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
Castall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
[TBL] [Abstract][Full Text] [Related]
22. Effects of chronic dietary lithium on behavioral indices of dopamine denervation supersensitivity in the rat.
Swerdlow NR; Lee D; Koob GF; Vaccarino FJ
J Pharmacol Exp Ther; 1985 Nov; 235(2):324-9. PubMed ID: 3932641
[TBL] [Abstract][Full Text] [Related]
23. Behavioural responses to stereotactically controlled injections of monoamine neurotransmitters into the accumbens and caudate-putamen nuclei.
Makanjuola RO; Dow RC; Ashcroft GW
Psychopharmacology (Berl); 1980; 71(3):227-35. PubMed ID: 6109349
[TBL] [Abstract][Full Text] [Related]
24. Intracerebroventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats.
Tieppo CA; Silva AM; Palermo-Neto J; Nasello AG; Felicio LF
Braz J Med Biol Res; 1995 Mar; 28(3):351-4. PubMed ID: 8520531
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamen.
Costall B; Naylor RJ; Cannon JG; Lee T
J Pharm Pharmacol; 1977 Jun; 29(6):337-42. PubMed ID: 18569
[No Abstract] [Full Text] [Related]
26. Behavioral effects of a dimethylsulfonium analog of dopamine after injection into the nucleus accumbens and the striatum.
Boldry R; Chang Y; Miller DD; Uretsky NJ
Pharmacol Biochem Behav; 1986 Feb; 24(2):223-8. PubMed ID: 3081914
[TBL] [Abstract][Full Text] [Related]
27. Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
Gou H; Wen D; Ma C; Li M; Li Y; Zhang W; Liu L; Cong B
Behav Brain Res; 2015 Apr; 283():87-96. PubMed ID: 25629941
[TBL] [Abstract][Full Text] [Related]
28. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
Kaneno S; Watanabe A; Takahashi R
Eur J Pharmacol; 1986 Apr; 123(2):287-94. PubMed ID: 3086109
[TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin modulation of apomorphine- or amphetamine-induced stereotypy in rats: opposite effects.
Tieppo CA; Felicio LF; Nasello AG
Peptides; 2001 Aug; 22(8):1291-8. PubMed ID: 11457523
[TBL] [Abstract][Full Text] [Related]
30. A behavioral pharmacological study on CCK-8 related peptides in mice.
Moroji T; Hagino Y
Neuropeptides; 1986 Oct; 8(3):273-86. PubMed ID: 3785587
[TBL] [Abstract][Full Text] [Related]
31. Increased neuronal responsiveness to cholecystokinin and dopamine induced by lesioning mesolimbic dopaminergic neurons: an electrophysiological study in the rat.
Debonnel G; de Montigny C
Synapse; 1988; 2(5):537-45. PubMed ID: 2903570
[TBL] [Abstract][Full Text] [Related]
32. CGS 10746B: an atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses.
Altar CA; Wasley AM; Liebman J; Gerhardt S; Kim H; Welch JJ; Wood PL
Life Sci; 1986 Aug; 39(8):699-705. PubMed ID: 2874470
[TBL] [Abstract][Full Text] [Related]
33. Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat.
Wallace TL; Gudelsky GA; Vorhees CV
J Neurosci; 1999 Oct; 19(20):9141-8. PubMed ID: 10516332
[TBL] [Abstract][Full Text] [Related]
34. Cholecystokinin potentiation of dopamine-mediated behaviors in the nucleus accumbens.
Crawley JN
Ann N Y Acad Sci; 1985; 448():283-92. PubMed ID: 3861122
[No Abstract] [Full Text] [Related]
35. The interaction of clonidine with dopamine-dependent behaviour in rodents.
Pycock CJ; Jenner PG; Marsden CD
Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):133-41. PubMed ID: 558529
[TBL] [Abstract][Full Text] [Related]
36. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent.
Costall B; Holmes SW; Kelly ME; Naylor RJ
Br J Pharmacol; 1985 Aug; 85(4):943-9. PubMed ID: 3862460
[TBL] [Abstract][Full Text] [Related]
37. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.
Imperato A; Scrocco MG; Bacchi S; Angelucci L
Eur J Pharmacol; 1990 Oct; 187(3):555-6. PubMed ID: 2150045
[No Abstract] [Full Text] [Related]
38. gamma-Endorphin and N alpha-acetyl-gamma-endorphin interfere with distinct dopaminergic systems in the nucleus accumbens via opioid and non-opioid mechanisms.
van Ree JM; Gaffori O; Kiraly I
Life Sci; 1984 Apr; 34(14):1317-24. PubMed ID: 6200747
[TBL] [Abstract][Full Text] [Related]
39. Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity.
Arnt J
Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):97-104. PubMed ID: 2864641
[TBL] [Abstract][Full Text] [Related]
40. Modulation of feeding and drinking behaviour by catecholamines injected into nucleus caudatus in rats.
Pal GK; Pal P; Raj SS; Mohan M
Indian J Physiol Pharmacol; 2001 Apr; 45(2):172-80. PubMed ID: 11480223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
